Xiao Bin Wu
Net worth: 32 M $ as of 2026-04-29
Net worth: 32 M $ as of 2026-04-29
Dr. Xiao Bin Wu is an Independent Non-Executive Director at Clover Biopharmaceuticals Ltd., a President & Chief Operating Officer at BeiGene Ltd., a Chairman at BeiGene Pharmaceuticals (Guangzhou) Co., Ltd., a Chairman & Manager at BeiGene (Guangzhou) Co., Ltd. and a Country Manager-China at Pfizer Pharmaceuticals Ltd. He is on the Board of Directors at Clover Biopharmaceuticals Ltd. He received his graduate degree from Universität Konstanz and a doctorate degree from Universität Konstanz.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-19 | 1,428,609 ( 0.1% ) | 32 M $ | 2026-04-29 | |
| 2026-04-01 | 607,000 ( 0.05% ) | 229 355 $ | 2026-04-29 |
| Companies | Position | Start |
|---|---|---|
| BEIGENE LTD | President | 2018-03-31 |
| CLOVER BIOPHARMACEUTICALS, LTD. | Director/Board Member | 2021-04-18 |
Pfizer Pharmaceuticals Ltd.
Pfizer Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Corporate Officer/Principal | 2011-08-22 |
BeiGene Pharmaceuticals (Guangzhou) Co. Ltd.
BeiGene Pharmaceuticals (Guangzhou) Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chairman | - |
BeiGene (Guangzhou) Co., Ltd.
BeiGene (Guangzhou) Co., Ltd. Financial ConglomeratesFinance Provides investment services | Chairman | - |
China Pharmaceutical Industry Research & Dev. Association | Director/Board Member | 2018-12-31 |
| Companies | Position | End |
|---|---|---|
Pfizer Essential Health
Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 2018-03-31 |
RDPAC
RDPAC Miscellaneous Commercial ServicesCommercial Services Operates as an association dedicated to elevate pharmaceutical innovation ecosystem in China | Director/Board Member | 2017-12-31 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Corporate Officer/Principal | 2008-12-31 |
| ░░░░░ ░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 12 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Universität Konstanz
Universität Konstanz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Pharmaceuticals Ltd.
Pfizer Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
Bayer Healthcare Co., Ltd.
Bayer Healthcare Co., Ltd. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
China National Association of Industry & Commerce | |
China Pharmaceutical Industry Research & Dev. Association | |
BeiGene Ltd.
BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Pfizer Essential Health
Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
BeiGene (Guangzhou) Co., Ltd.
BeiGene (Guangzhou) Co., Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
BeiGene Pharmaceuticals (Guangzhou) Co. Ltd.
BeiGene Pharmaceuticals (Guangzhou) Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Clover Biopharmaceuticals Ltd.
Clover Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
RDPAC
RDPAC Miscellaneous Commercial ServicesCommercial Services Operates as an association dedicated to elevate pharmaceutical innovation ecosystem in China | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions